What's breaking now, across thousands of outlets.
The startup is working on a medicine one of its investors claimed could have a broader reach than other approved drugs for a group of conditions known as myeloproliferative neoplasms.
We haven't written up this one. BioPharma Dive has the full story — the link below goes straight to it.
We have selected seven Lifestyle stories from the past seven days that resonated with our readers. If you would like to see more of our reporting, please consider subscribing. 1.
By Kwame Bediako Ghana Football Association president Kurt Okraku says the GFA lost a potential sponsorship worth more than $5 million a year for the Ghana Premier League after the Food and Drugs…
About a year after emerging from stealth, University of Oxford spinout Alethio Therapeutics has collected $90 million in a Series A raise to support its lead rare blood cancer program through ...
Finding effective treatments for Alzheimer’s disease has long been a challenge. While traditional clinical trials test a single drug over […]
Dubai: A new luxury hospital featuring a comprehensive cancer centre, robotic-assisted surgery, advanced cardiac care and a dedicated water birth unit is set to open in Dubai Studio City by 2029…
